53556-U

Ascentis^® Express 90 Å PAH (2.7 μm) HPLC Columns

L × I.D. 0.5 cm × 4.6 mm, HPLC Guard Cartridge

• Synonym(e): Ascentis^® Express 90 Å PAH, 2.7 μm HPLC Column
• UNSPSC-Code: 41115709
• NACRES: SB.52

Eigenschaften

• product name: Ascentis^® Express 90 Å PAH, 2.7 μm HPLC Guard Cartridge, pack of 3 ea, cartridge L × I.D. 0.5 cm × 4.6 mm
• Materialien: stainless steel column
• Qualitätsniveau: 100
• Agentur: suitable for USP L1
• Produktlinie: Ascentis^®
• Leistungsmerkmale: endcapped: no
• Verpackung: pack of 3 ea
• Kennzeichnungsgrad: 9.9% Carbon loading
• Parameter: ≤60 °C temp. limit; ≤600 bar max. pressure
• Methode(n): HPLC: suitable; LC/MS: suitable
• Kartusche L × ID: 0.5 cm × 4.6 mm
• Oberflächenbereich: 135 m²/g
• Matrix: Fused-Core^® silica particle platform particle platform; superficially porous particle
• Aktive Matrixgruppe: C18 bonded phase optimized for PAH analysis
• Partikelgröße: 2.7 μm
• Porengröße: 90 Å pore size
• operating pH range: 2-9
• Trenntechnik: reversed phase

Beschreibung

Allgemeine Beschreibung

Ascentis^® Express PAH is a high-speed, high-performance liquid chromatography column based on the proven Fused-Core^® particle design. The Fused-Core^® particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.5 μm thick porous shell and the small overall particle size of 2.7 μm. The unendcapped trifunctional C18 stationary phase of Ascentis^® Express PAH provides a stable, reversed-phase packing that can be used for analysis of acids, bases, and zwitterionic compounds, but has been specifically designed for the separation of polycyclic aromatic hydrocarbons.

Hinweis zur Analyse

The target analytes include polycyclic aromatic hydrocarbons (PAHs), acids, bases, and zwitterionic compounds.

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.